Synthesis of 3-alkyl(aryl)-4-alkylidenamino-4,5-dihydro-1H-1,2,4-triazol-5-ones and 3-alkyl-4-alkylamino-4,5-dihydro-1H-1,2,4-triazol-5-ones as antitumor agents

被引:269
作者
Demirbas, N [1 ]
Ugurluoglu, R [1 ]
Demirbas, A [1 ]
机构
[1] Karadeniz Tech Univ, Dept Chem, TR-61080 Trabzon, Turkey
关键词
D O I
10.1016/S0968-0896(02)00420-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of 3-alkyl-4-phenylethylidenamino- (8) and 3-alkyl-4-(3-phenylallylidenamino)-4,5-dihydro-1H-1,2,4-triazol-5-ones (9) was synthesized from the reaction of the corresponding 3-alkyl(aryl)-4-amino-4,5-dihydro-1H-1,2,4-triazol-5-ones (1), with phenylacetaldehyde and cinnamaldehyde, 3-Alkyl-4-(2-phenylethyamino)- (10) and 3-alkyl-4-(3-phenylpropylamino)-4,5dihydro- 1H-1,2,4-triazol-5-ones (11) were obtained from the selective reduction of compounds (8) and (9) with NaBH4. The in vitro antitumor activity of the novel compounds was screened and the highest inhibition of tree tumor cell lines was observed for the compounds containing phenylethylenamino and phenylethylamino groups at position 4 of 1,2,4-triazol ring. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3717 / 3723
页数:7
相关论文
共 34 条
[1]  
ADDEL M, 1999, HETEROCYCLES, V51, P379
[2]   Antimicrobial and antitumor activity of N-heteroimmine-1,2,3-dithiazoles and their transformation in triazolo-, imidazo-, and pyrazolopirimidines [J].
Baraldi, PG ;
Pavani, MG ;
Nuñez, MD ;
Brigidi, P ;
Vitali, B ;
Gambari, R ;
Romagnoli, R .
BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (02) :449-456
[3]   H-2-ANTIHISTAMINICS .35. SYNTHESIS AND H-2-ANTAGONISTIC ACTIVITY OF IMIDAZOLYLMETHYLTHIOALKYL-SUBSTITUTED 1,2,4-TRIAZOLES [J].
BONJEAN, J ;
SCHUNACK, W .
ARCHIV DER PHARMAZIE, 1987, 320 (06) :554-562
[4]   FUNGICIDAL ACTIVITY OF A SERIES OF 1-SUBSTITUTED-1-ARYL-2-TRIAZOL-1-YL-ETHANOLS [J].
CHOLLET, JF ;
BONNEMAIN, JL ;
MIGINIAC, L ;
ROHR, O .
PESTICIDE SCIENCE, 1990, 29 (04) :427-435
[5]  
CLEMENSE F, 1985, EUR J MED CHEM, V20, P250
[6]   Synthesis and antimicrobial activities of some 3-arylamino-5-[2(substituted 1-imidazolyl)ethyl]-1,2,4-triazole derivatives [J].
Demirayak, S ;
Benkli, K ;
Güven, K .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (11) :1037-1040
[7]  
Demirbas A, 1996, Acta Pol Pharm, V53, P117
[8]  
EMILSSON H, 1985, EUR J MED CHEM, V20, P333
[9]  
EMILSSON H, 1986, EUR J MED CHEM, V21, P235
[10]  
Gray GD, 1996, BIOTECHNIQUES, V21, P780